William Anderson is an American business executive who has been the chief executive officer of Bayer AG since June 2023.
Prior to his current role, Anderson was CEO of Genentech from 2017 to 2018, and later CEO of the Roche's Pharmaceuticals Division from 2019 to 2022.
